Markku Laakso
Impact in
- Endocrinology, Diabetes and Metabolism top 0.01%
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Diabetes Treatment and Management
- Diabetes Management and Research
- Geriatrics and Gerontology top 0.05%
Papers in
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 157
- Physiology 188
- Adipose Tissue and Metabolism 111
- Diet and metabolism studies 65
- Co-authors
- Kalevi PyörälàSeppo LehtoTapani RönnemaaSteven M. HaffnerJohanna KuusistoLeena MykkänenMatti UusitupaM Hanefeld
- Journals
- Diabetes Care (51 papers)Diabetes (46 papers)Diabetologia (40 papers)The Journal of Clinical Endocrinology & Metabolism (33 papers)Atherosclerosis (21 papers)
- Partner nations
- FinlandUnited StatesSweden
In The Last Decade
Markku Laakso
664 papers receiving 55.7k citations
Hit Papers
Peers
Comparison fields: 5 of 194
- Endocrinology, Diabetes and Metabolism 23.4k
- Geriatrics and Gerontology 2.3k
- Cardiology and Cardiovascular Medicine 13.0k
- Physiology 13.5k
- Epidemiology 9.8k
Countries citing papers authored by Markku Laakso
This map shows the geographic impact of Markku Laakso's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markku Laakso with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markku Laakso more than expected).
Fields of papers citing papers by Markku Laakso
This network shows the impact of papers produced by Markku Laakso. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markku Laakso. The network helps show where Markku Laakso may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Markku Laakso, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 8 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 2 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 4 | |
| 6 | 2023 | 5 | |
| 7 | 2023 | 16 | |
| 8 | 2022 | 49 | |
| 9 | 2022 | 9 | |
| 10 | 2022 | 9 | |
| 11 | 2021 | 20 | |
| 12 | 2021 | 51 | |
| 13 | 2019 | 14 | |
| 14 | 2012 | 168 | |
| 15 | 2012 | 203 | |
| 16 | Kliininen tutkimus Suomessa : tutkimuksen rakenteet | 2012 | 1 |
| 17 | 2008 | 67 | |
| 18 | 2006 | 16 | |
| 19 | 1997 | 26 | |
| 20 | 1995 | 78 |
About Markku Laakso
Markku Laakso is a scholar working on Endocrinology, Diabetes and Metabolism, Physiology, Cardiology and Cardiovascular Medicine, Endocrine and Autonomic Systems and Epidemiology, having authored 673 papers that have together received 58.2k indexed citations. Recurring topics across this work include Diabetes, Cardiovascular Risks, and Lipoproteins (157 papers), Adipose Tissue and Metabolism (111 papers), Metabolism, Diabetes, and Cancer (97 papers), Adipokines, Inflammation, and Metabolic Diseases (68 papers), Cardiovascular Function and Risk Factors (67 papers), Diet and metabolism studies (65 papers), Pancreatic function and diabetes (64 papers) and Peroxisome Proliferator-Activated Receptors (58 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (23.4k citations), Geriatrics and Gerontology (2.3k citations), Cardiology and Cardiovascular Medicine (13.0k citations), Physiology (13.5k citations) and Epidemiology (9.8k citations). Markku Laakso has collaborated with scholars based in Finland, United States and Sweden. Frequent co-authors include Kalevi Pyörälà, Seppo Lehto, Tapani Rönnemaa, Steven M. Haffner, Johanna Kuusisto, Leena Mykkänen, Matti Uusitupa, M Hanefeld, Jussi Pihlajamäki and Jean‐Louis Chiasson. Their work appears in journals such as Diabetes Care, Diabetes, Diabetologia, The Journal of Clinical Endocrinology & Metabolism and Atherosclerosis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.